Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Loperamide and Adrenocorticotropic Hormone

Research Papers that Mention the Interaction

Although these findings might be explained by the involvement of different intracellular ACTH-secreting mechanisms, an influence of loperamide on some suprapituitary factors modulating the ACTH response is suggested.
Loperamide is a peripheral opiate agonist able to inhibit ACTH secretion.
Neuroendocrinology  •  1988  |  View Paper
While in controls … DXM and LOP strongly suppressed plasma cortisol and ACTH , in Cushing’s disease and in incidentalomas no patient showed a decrease in cortisol levels below 50 ng/ml or a reduction in plasma cortisol greater than 50% of basal values in response to LOP and DXM.
Journal of endocrinological investigation  •  1994  |  View Paper
Loperamide is a drug that acts as an opiate agonist and is able to inhibit corticotropin levels in normal subjects and in patients with Addison's disease, but not in patients with Cushing's syndrome.
JAMA  •  1993  |  View Paper
In summary, loperamide is able to reduce basal and CRH-induced ACTH and cortisol levels in normal subjects, but not in patients with Cushing's disease or secondary adrenal failure of hypothalamic origin.
Loperamide , an opiate agonist of high specificity for mu-receptors, was recently reported to suppress ACTH and cortisol levels in normal subjects, but not in patients with proven ACTH-dependent Cushing's disease.
The Journal of clinical endocrinology and metabolism  •  1992  |  View Paper
In 3 patients treated with antiepileptic drugs ACTH and Cortisol levels were inhibited by loperamide , but not by dexamethasone.
In normal subjects plasma ACTH and Cortisol levels were significantly (p < 0.005) suppressed by both loperamide (16 mg po) and dexamethasone (1 mg po).
Journal of endocrinological investigation  •  1989  |  View Paper
These data suggest that the inhibitory role of loperamide on ACTH secretion is exerted at supra-pituitary level, although a pituitary site of action can not be excluded.
Hormone and metabolic research. Supplement series  •  1987  |  View Paper
After 3.5 h, loperamide (10 microM) had no effect on basal ACTH levels but significantly suppressed CRH-induced ACTH release, in a dose-dependent manner, to 60 +/- 4% of control (100%) (p < 0.0001).
Loperamide did not influence basal and CRH-induced adenylate cyclase activity in anterior pituitary cell membrane preparations, but it significantly blunted Bu(2)cAMP-induced ACTH secretion in cell culture from 100 +/- 4 to 77 +/- 4% (p < 0.05).
Neuroendocrinology  •  1993  |  View Paper